CRANBURY, N.J.--(BUSINESS WIRE)--Physicians’ Education Resource® (PER®), a leading resource for continuing medical education (CME), will conduct two CME-accredited satellite symposia on bladder cancer and renal cell carcinoma at the 2019 American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium on Feb. 14 and 15 at the San Francisco Marriott Marquis in California, announced Phil Talamo, president of PER®.
“We are thrilled to host two different programs on the changing landscape of treating bladder cancer and renal cell carcinoma during this year’s ASCO GU,” Talamo said. “Our educational programs will feature experienced experts presenting new clinical evidence to help attendees make decisions on selecting the best therapies to optimize patient outcomes in two very difficult to treat tumor settings.”
The PER® satellite symposiums are:
- Shifting Paradigms in Bladder Cancer: How Immunotherapeutic Strategies Are Changing Courses of Care will be held on Thursday, Feb. 14, from 7 to 9 p.m. PST in the Salon 8 Yerba Buena Ballroom, Lower B2 Level. The symposia will be chaired by Daniel P. Petrylak, M.D., professor of medicine and urology at Yale School of Medicine and co-director of the Signal Transduction Research Program at Yale Cancer Center. During this interactive symposium, renowned experts will discuss the impact of evolving evidence on the use of immuno-oncology agents, including combination strategies, in the management of bladder cancers. To register, click here.
- Medical Crossfire®: Crossroads in Advanced RCC Decision-Making: With Many Options, How Will You Treat Your Patient Today? … And Tomorrow? will be held on Friday, Feb. 15, from 7 to 9 p.m. PST in the Salon 8 Yerba Buena Ballroom, Lower B2 Level. The symposia will be chaired by Toni K. Choueiri, M.D., director of the Lank Center for Genitourinary Oncology, director of the Kidney Cancer Center, a senior physician at Dana-Farber Cancer Institute, and the Jerome and Nancy Kohlberg chair and professor of medicine at Harvard Medical School. During this case-based, interactive, live symposium, distinguished faculty members will review the most recent data and best practices. A lively debate and discussion between faculty and attendees will address clinical challenges and questions faced in daily practice. To register, click here.
Each satellite symposium is accredited by the Accreditation Council for Continuing Medical Education for 2.0 AMA PRA Category 1 Credits™ for physicians.
About Physicians’ Education Resource® (PER®)
Since 1995, PER® has been dedicated to advancing cancer care through professional education and now furthers patient care and treatment strategies on a wide variety of chronic illnesses and diseases. In 2016, PER® initiated CME programming in the cardiovascular and endocrinology areas and continues to grow its therapeutic reach. While expanding into topics outside of oncology, PER® remains the leading provider of live, online and print CME activities related to oncology and hematology. The high-quality, evidence-based activities feature leading distinguished experts who focus on the application of practice-changing advances. PER® is accredited by the Accreditation Council for Continuing Medical Education and the California Board of Registered Nursing. PER® is part of the Cranbury, New Jersey-based MJH Associates Inc. family of businesses. Learn more at http://www.gotoper.com and http://www.mjhassoc.com.
